Free Trial
TSE:SVA

Sernova (SVA) Stock Price, News & Analysis

Sernova logo
C$0.18 -0.01 (-5.41%)
As of 03:59 PM Eastern

About Sernova Stock (TSE:SVA)

Key Stats

Today's Range
C$0.18
C$0.19
50-Day Range
C$0.15
C$0.21
52-Week Range
C$0.15
C$0.34
Volume
71,113 shs
Average Volume
130,518 shs
Market Capitalization
C$58.89 million
P/E Ratio
N/A
Dividend Yield
7.86%
Price Target
C$2.00
Consensus Rating
Buy

Company Overview

Sernova Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
32nd Percentile Overall Score

SVA MarketRank™: 

Sernova scored higher than 32% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Sernova has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Sernova has received no research coverage in the past 90 days.

  • Read more about Sernova's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Sernova is -1.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Sernova is -1.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Short Interest

    There is no current short interest data available for SVA.
  • Dividend Leadership

    Sernova is a leading dividend payer. It pays a dividend yield of 7.86%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Sernova does not have a long track record of dividend growth.

  • Read more about Sernova's dividend.
  • Short Interest

    There is no current short interest data available for SVA.
  • MarketBeat Follows

    Only 1 people have added Sernova to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Sernova insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    12.13% of the stock of Sernova is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 0.05% of the stock of Sernova is held by institutions.

  • Read more about Sernova's insider trading history.
Receive SVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sernova and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SVA Stock News Headlines

Sernova Biotherapeutics Inc (SVA.TO) - Yahoo Finance Canada
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.tc pixel
SVA:CA Sernova Biotherapeutics Inc - Seeking Alpha
Stocks in play: Sernova Biotherapeutics
Sernova Biotherapeutics Inc SVA
Sernova Biotherapeutics Inc (SVA.TO)
See More Headlines

SVA Stock Analysis - Frequently Asked Questions

Sernova's stock was trading at C$0.23 on January 1st, 2025. Since then, SVA shares have decreased by 20.0% and is now trading at C$0.18.

Shares of SVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sernova investors own include ARC Resources (ARX), Meta Platforms (META), Newron Pharmaceuticals (NWPHF), Sernova Biotherapeutics (SEOVF), AMC Entertainment (AMC), Advanced Micro Devices (AMD) and CloudMD Software & Services (DOC).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
TSE:SVA
CIK
N/A
Fax
N/A
Employees
1,959
Year Founded
N/A

Price Target and Rating

High Price Target
C$2.50
Low Price Target
C$1.50
Potential Upside/Downside
+1,011.1%
Consensus Rating
Buy
Rating Score (0-4)
3.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
C($0.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$35.70 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
473.85%
Return on Assets
-119.26%

Debt

Debt-to-Equity Ratio
-4.40
Current Ratio
0.32
Quick Ratio
18.11

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.03 per share
Price / Cash Flow
6.15
Book Value
C($0.04) per share
Price / Book
-4.22

Miscellaneous

Outstanding Shares
336,496,829
Free Float
N/A
Market Cap
C$60.57 million
Optionable
Not Optionable
Beta
1.35
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (TSE:SVA) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners